About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 203 record(s)
Req # A-2022-09061
Copy of the resignation letter of the Vice-Chair Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
January 2023
Req # A-2021-10764
Copies of all emails to/from/cc'ing all Directors from May 31, 2021 to June 4, 2021.Organization: Patented Medicine Prices Review Board Canada
December 2022
Req # A-2022-09059
Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th. So this request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well.Organization: Patented Medicine Prices Review Board Canada
December 2022
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2022-01918
Copies of the number of every patent reported to the PMPRB, via Form 1 Patent List or otherwise, with respect to Keytruda pembrolizumab.Organization: Patented Medicine Prices Review Board Canada
September 2022
Req # A-2021-10763
Copies of all emails to/from/cc'ing all Directors from May 21, 2021 to May 30, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2022
Req # A-2021-10773
Copies of all emails sent by external sources to the PMPRB and Douglas Clark from May 22, 2021 to June 14, 2021.Organization: Patented Medicine Prices Review Board Canada
August 2022
Req # A-2022-13654
Electronic copies of the following documents: 1. A copy of every advance ruling certificate (ARC) issued by the Board, including any reasons in support of the ARC issued by the Board. 2. A copy of the Notice and Comment issued by the Board in response to each of the ARCs. 3. A copy of the patentee's submissions (including any affidavits or other evidence) on each of the ARCs. The Board's ARC for Viread indicates that these submissions are available upon request. 4. A copy of the Board Staff's submissions (including any affidavits or other evidence) on each of the ARCs. Again, the Board's Viread ARC indicates that these are available upon request. 5. A copy of any other submissions received in response to the notice of and comment.Organization: Patented Medicine Prices Review Board Canada
July 2022
Req # A-2021-10645
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and BIOTECanada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
June 2022